Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NKTR
NKTR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NKTR News
Nektar's Therapy Shows Significant Hair Growth Results
8h ago
stocktwits
Nektar Therapeutics Launches $250 Million Public Offering
1h ago
seekingalpha
Nektar Therapeutics Faces Class Action Lawsuit
8h ago
Globenewswire
Nektar Therapeutics Reports Positive Phase 2b Data for Alopecia Areata Treatment
10h ago
seekingalpha
Nektar's Rezpegaldesleukin Shows Significant Improvement in Alopecia Treatment
11h ago
PRnewswire
Nektar's Rezpegaldesleukin Shows Significant Efficacy in Treating Alopecia Areata
11h ago
Newsfilter
Nektar Therapeutics to Host Investor Call on Phase 2b Trial Results
1d ago
PRnewswire
Nektar Therapeutics to Review Phase 2b REZOLVE-AA Trial Results on April 20, 2026
1d ago
Newsfilter
Nektar to Host Investor Call on REZOLVE-AA Results
1d ago
Yahoo Finance
Reminder of Class Action for Nektar Therapeutics Investors
1d ago
Globenewswire
Class Action Filed Against Nektar Therapeutics
3d ago
Globenewswire
Class Action Lawsuits Filed Against Boston Scientific and Others
4d ago
Globenewswire
Nektar Therapeutics Faces Class Action Lawsuit
4d ago
Globenewswire
Reminder for Nektar Therapeutics Class Action Deadline
4d ago
PRnewswire
Reminder of Class Action for Nektar Therapeutics Investors
4d ago
Globenewswire
Multiple Companies Face Class Action Lawsuits
4d ago
Globenewswire
Show More News
